ID UPAR_MOUSE Reviewed; 327 AA. AC P35456; P35457; DT 01-JUN-1994, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-1994, sequence version 1. DT 24-JAN-2024, entry version 172. DE RecName: Full=Urokinase plasminogen activator surface receptor; DE Short=U-PAR; DE Short=uPAR; DE AltName: CD_antigen=CD87; DE Flags: Precursor; GN Name=Plaur; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND ALTERNATIVE SPLICING. RC TISSUE=Macrophage; RX PubMed=1661735; DOI=10.1083/jcb.115.6.1763; RA Kristensen P., Eriksen J., Blasi F., Danoe K.; RT "Two alternatively spliced mouse urokinase receptor mRNAs with different RT histological localization in the gastrointestinal tract."; RL J. Cell Biol. 115:1763-1771(1991). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=7929309; DOI=10.1016/s0021-9258(18)47149-9; RA Suh T.T., Nerlov C., Dano K., Degen J.L.; RT "The murine urokinase-type plasminogen activator receptor gene."; RL J. Biol. Chem. 269:25992-25998(1994). RN [3] RP INTERACTION WITH SRPX2, AND TISSUE SPECIFICITY. RX PubMed=19667118; DOI=10.1096/fj.09-135202; RA Miljkovic-Licina M., Hammel P., Garrido-Urbani S., Bradfield P.F., RA Szepetowski P., Imhof B.A.; RT "Sushi repeat protein X-linked 2, a novel mediator of angiogenesis."; RL FASEB J. 23:4105-4116(2009). RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Lung; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [5] RP X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 24-300 IN COMPLEX WITH PLAU, RP DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-75; ASN-193 AND ASN-282. RX PubMed=20133942; DOI=10.1074/jbc.m109.093492; RA Lin L., Gardsvoll H., Huai Q., Huang M., Ploug M.; RT "Structure-based engineering of species selectivity in the interaction RT between urokinase and its receptor: implication for preclinical cancer RT therapy."; RL J. Biol. Chem. 285:10982-10992(2010). CC -!- FUNCTION: Acts as a receptor for urokinase plasminogen activator. Plays CC a role in localizing and promoting plasmin formation. Mediates the CC proteolysis-independent signal transduction activation effects of U-PA. CC -!- SUBUNIT: Monomer (Probable). Interacts (via the UPAR/Ly6 domains) with CC SRPX2. Interacts with MRC2 (By similarity). Interacts with SORL1 (via CC N-terminal ectodomain); this interaction decreases PLAUR CC internalization (By similarity). The ternary complex composed of PLAUR- CC PLAU-SERPINE1 also interacts with SORL1 (By similarity). {ECO:0000250, CC ECO:0000250|UniProtKB:Q03405, ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane CC {ECO:0000250|UniProtKB:P49616}; Lipid-anchor, GPI-anchor CC {ECO:0000250|UniProtKB:P49616}. CC -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted CC {ECO:0000250|UniProtKB:P49616}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; Synonyms=GPI-anchored; CC IsoId=P35456-1; Sequence=Displayed; CC Name=2; Synonyms=Secreted; CC IsoId=P35456-2, P35457-1; Sequence=VSP_031837, VSP_031838; CC -!- TISSUE SPECIFICITY: Expressed in angiogenic endothelial cells (at CC protein level). {ECO:0000269|PubMed:19667118}. CC -!- MISCELLANEOUS: [Isoform 1]: GPI-anchored form. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X62700; CAA44574.1; -; mRNA. DR EMBL; X62701; CAA44575.1; -; mRNA. DR EMBL; U12235; AAB60484.1; -; Genomic_DNA. DR CCDS; CCDS20950.1; -. [P35456-1] DR PIR; A55356; A55356. DR PIR; B41643; B41643. DR RefSeq; NP_035243.1; NM_011113.4. [P35456-1] DR RefSeq; XP_006539702.1; XM_006539639.3. DR RefSeq; XP_006539703.1; XM_006539640.3. DR PDB; 3LAQ; X-ray; 3.20 A; U/V=24-300. DR PDB; 6AEX; X-ray; 2.39 A; U=24-300. DR PDBsum; 3LAQ; -. DR PDBsum; 6AEX; -. DR AlphaFoldDB; P35456; -. DR SMR; P35456; -. DR ComplexPortal; CPX-510; uPA-uPAR complex. DR ComplexPortal; CPX-526; uPA-uPAR-vitronectin complex. DR CORUM; P35456; -. DR IntAct; P35456; 1. DR STRING; 10090.ENSMUSP00000002284; -. DR GlyCosmos; P35456; 7 sites, No reported glycans. DR GlyGen; P35456; 7 sites. DR iPTMnet; P35456; -. DR PhosphoSitePlus; P35456; -. DR SwissPalm; P35456; -. DR MaxQB; P35456; -. DR PaxDb; 10090-ENSMUSP00000002284; -. DR PeptideAtlas; P35456; -. DR ProteomicsDB; 300097; -. [P35456-1] DR ProteomicsDB; 300098; -. [P35456-2] DR Antibodypedia; 31096; 733 antibodies from 42 providers. DR DNASU; 18793; -. DR Ensembl; ENSMUST00000002284.11; ENSMUSP00000002284.10; ENSMUSG00000046223.11. [P35456-1] DR GeneID; 18793; -. DR KEGG; mmu:18793; -. DR UCSC; uc009fpr.1; mouse. [P35456-1] DR AGR; MGI:97612; -. DR CTD; 5329; -. DR MGI; MGI:97612; Plaur. DR VEuPathDB; HostDB:ENSMUSG00000046223; -. DR eggNOG; ENOG502S36D; Eukaryota. DR GeneTree; ENSGT00940000153599; -. DR HOGENOM; CLU_072612_0_0_1; -. DR InParanoid; P35456; -. DR OMA; TGNGCNH; -. DR OrthoDB; 4599852at2759; -. DR PhylomeDB; P35456; -. DR TreeFam; TF338662; -. DR Reactome; R-MMU-162791; Attachment of GPI anchor to uPAR. DR Reactome; R-MMU-6798695; Neutrophil degranulation. DR Reactome; R-MMU-75205; Dissolution of Fibrin Clot. DR BioGRID-ORCS; 18793; 2 hits in 79 CRISPR screens. DR EvolutionaryTrace; P35456; -. DR PRO; PR:P35456; -. DR Proteomes; UP000000589; Chromosome 7. DR RNAct; P35456; Protein. DR Bgee; ENSMUSG00000046223; Expressed in granulocyte and 135 other cell types or tissues. DR ExpressionAtlas; P35456; baseline and differential. DR GO; GO:0009986; C:cell surface; ISO:MGI. DR GO; GO:0009897; C:external side of plasma membrane; NAS:ComplexPortal. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0005886; C:plasma membrane; IDA:MGI. DR GO; GO:0098637; C:protein complex involved in cell-matrix adhesion; ISO:MGI. DR GO; GO:1905370; C:serine-type endopeptidase complex; IPI:ComplexPortal. DR GO; GO:0019899; F:enzyme binding; ISO:MGI. DR GO; GO:0019904; F:protein domain specific binding; ISO:MGI. DR GO; GO:0005102; F:signaling receptor binding; ISO:MGI. DR GO; GO:0060742; P:epithelial cell differentiation involved in prostate gland development; ISO:MGI. DR GO; GO:0048762; P:mesenchymal cell differentiation; ISO:MGI. DR GO; GO:0043066; P:negative regulation of apoptotic process; ISO:MGI. DR GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; ISO:MGI. DR GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; ISO:MGI. DR GO; GO:0034112; P:positive regulation of homotypic cell-cell adhesion; ISO:MGI. DR GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:MGI. DR GO; GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; ISO:MGI. DR GO; GO:0030155; P:regulation of cell adhesion; ISO:MGI. DR GO; GO:0051917; P:regulation of fibrinolysis; NAS:ComplexPortal. DR GO; GO:0010755; P:regulation of plasminogen activation; NAS:ComplexPortal. DR GO; GO:0038195; P:urokinase plasminogen activator signaling pathway; NAS:ComplexPortal. DR CDD; cd00117; LU; 3. DR Gene3D; 2.10.60.10; CD59; 3. DR InterPro; IPR018363; CD59_antigen_CS. DR InterPro; IPR016054; LY6_UPA_recep-like. DR InterPro; IPR045860; Snake_toxin-like_sf. DR PANTHER; PTHR10624:SF6; UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR; 1. DR PANTHER; PTHR10624; UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR-RELATED; 1. DR Pfam; PF00021; UPAR_LY6; 3. DR SMART; SM00134; LU; 3. DR SUPFAM; SSF57302; Snake toxin-like; 3. DR PROSITE; PS00983; LY6_UPAR; 3. DR Genevisible; P35456; MM. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cell membrane; Disulfide bond; KW Glycoprotein; GPI-anchor; Lipoprotein; Membrane; Receptor; KW Reference proteome; Repeat; Secreted; Signal. FT SIGNAL 1..23 FT /evidence="ECO:0000255" FT CHAIN 24..?298 FT /note="Urokinase plasminogen activator surface receptor" FT /id="PRO_0000036096" FT PROPEP ?299..327 FT /note="Removed in mature form" FT /evidence="ECO:0000255" FT /id="PRO_0000036097" FT DOMAIN 24..117 FT /note="UPAR/Ly6 1" FT DOMAIN 117..212 FT /note="UPAR/Ly6 2" FT DOMAIN 213..298 FT /note="UPAR/Ly6 3" FT LIPID 298 FT /note="GPI-anchor amidated glycine" FT /evidence="ECO:0000255" FT CARBOHYD 32 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 75 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:20133942" FT CARBOHYD 183 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 193 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:20133942" FT CARBOHYD 221 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 254 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 282 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 26..47 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 29..35 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 40..68 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 94..99 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 119..146 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 122..129 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 139..168 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 174..191 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 192..197 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 215..243 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 218..226 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 236..262 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 268..287 FT /evidence="ECO:0000269|PubMed:20133942" FT DISULFID 288..293 FT /evidence="ECO:0000269|PubMed:20133942" FT VAR_SEQ 157..222 FT /note="RSLKDEDYTRGCGSLPGCPGTAGFHSNQTFHFLKCCNYTHCNGGPVLDLQSF FT PPNGFQCYSCEGNN -> SKLPSAGQLLVEIFKSWEQSASKRQLNPHTVTGPTFSVTGS FT SGSLDQLGSDQEPSYLVMSRILLSF (in isoform 2)" FT /evidence="ECO:0000303|PubMed:1661735" FT /id="VSP_031837" FT VAR_SEQ 223..327 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:1661735" FT /id="VSP_031838" FT STRAND 25..29 FT /evidence="ECO:0007829|PDB:3LAQ" FT STRAND 36..39 FT /evidence="ECO:0007829|PDB:3LAQ" FT STRAND 47..56 FT /evidence="ECO:0007829|PDB:3LAQ" FT STRAND 61..68 FT /evidence="ECO:0007829|PDB:3LAQ" FT STRAND 76..82 FT /evidence="ECO:0007829|PDB:3LAQ" FT STRAND 85..91 FT /evidence="ECO:0007829|PDB:3LAQ" FT STRAND 117..123 FT /evidence="ECO:0007829|PDB:6AEX" FT TURN 124..127 FT /evidence="ECO:0007829|PDB:3LAQ" FT TURN 128..130 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 131..133 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 135..139 FT /evidence="ECO:0007829|PDB:6AEX" FT TURN 141..143 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 145..152 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 163..169 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 175..181 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 186..192 FT /evidence="ECO:0007829|PDB:6AEX" FT TURN 195..198 FT /evidence="ECO:0007829|PDB:6AEX" FT HELIX 205..207 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 210..218 FT /evidence="ECO:0007829|PDB:6AEX" FT TURN 228..230 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 232..237 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 242..249 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 257..263 FT /evidence="ECO:0007829|PDB:6AEX" FT HELIX 265..269 FT /evidence="ECO:0007829|PDB:6AEX" FT TURN 272..276 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 277..280 FT /evidence="ECO:0007829|PDB:6AEX" FT STRAND 282..288 FT /evidence="ECO:0007829|PDB:6AEX" FT TURN 291..294 FT /evidence="ECO:0007829|PDB:6AEX" SQ SEQUENCE 327 AA; 35428 MW; A117441D738B6343 CRC64; MGLPRRLLLL LLLATTCVPA SQGLQCMQCE SNQSCLVEEC ALGQDLCRTT VLREWQDDRE LEVVTRGCAH SEKTNRTMSY RMGSMIISLT ETVCATNLCN RPRPGARGRA FPQGRYLECA SCTSLDQSCE RGREQSLQCR YPTEHCIEVV TLQSTERSLK DEDYTRGCGS LPGCPGTAGF HSNQTFHFLK CCNYTHCNGG PVLDLQSFPP NGFQCYSCEG NNTLGCSSEE ASLINCRGPM NQCLVATGLD VLGNRSYTVR GCATASWCQG SHVADSFPTH LNVSVSCCHG SGCNSPTGGA PRPGPAQLSL IASLLLTLGL WGVLLWT //